ATE196926T1 - Gen grb3-3, variante und ihre verwendungen - Google Patents

Gen grb3-3, variante und ihre verwendungen

Info

Publication number
ATE196926T1
ATE196926T1 AT94915598T AT94915598T ATE196926T1 AT E196926 T1 ATE196926 T1 AT E196926T1 AT 94915598 T AT94915598 T AT 94915598T AT 94915598 T AT94915598 T AT 94915598T AT E196926 T1 ATE196926 T1 AT E196926T1
Authority
AT
Austria
Prior art keywords
grb3
gen
variant
protein
sequences
Prior art date
Application number
AT94915598T
Other languages
English (en)
Inventor
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE196926T1 publication Critical patent/ATE196926T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT94915598T 1993-09-15 1994-05-09 Gen grb3-3, variante und ihre verwendungen ATE196926T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9310971A FR2710074B1 (fr) 1993-09-15 1993-09-15 Gène GRB3-3, ses variants et leurs utilisations.
PCT/FR1994/000542 WO1995007981A1 (fr) 1993-09-15 1994-05-09 Gene grb3-3, ses variants et leurs utilisations

Publications (1)

Publication Number Publication Date
ATE196926T1 true ATE196926T1 (de) 2000-10-15

Family

ID=9450882

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94915598T ATE196926T1 (de) 1993-09-15 1994-05-09 Gen grb3-3, variante und ihre verwendungen

Country Status (27)

Country Link
US (2) USRE37952E1 (de)
EP (1) EP0719328B1 (de)
JP (1) JP3794697B2 (de)
KR (1) KR100330477B1 (de)
CN (1) CN1098930C (de)
AT (1) ATE196926T1 (de)
AU (1) AU698819B2 (de)
BR (1) BR9407693A (de)
CA (1) CA2169938A1 (de)
CZ (1) CZ288882B6 (de)
DE (1) DE69426121T2 (de)
DK (1) DK0719328T3 (de)
ES (1) ES2152313T3 (de)
FI (1) FI120499B (de)
FR (1) FR2710074B1 (de)
GR (1) GR3034600T3 (de)
HU (1) HU221516B (de)
IL (2) IL110942A (de)
NO (1) NO319144B1 (de)
NZ (1) NZ266162A (de)
PL (1) PL178402B1 (de)
PT (1) PT719328E (de)
RU (1) RU2159815C2 (de)
SK (1) SK281123B6 (de)
UA (1) UA46715C2 (de)
WO (1) WO1995007981A1 (de)
ZA (1) ZA947059B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732348B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Systeme d'expression conditionnel
US5837844A (en) * 1995-06-07 1998-11-17 Biogen, Inc. CAIP-like gene family
US6171800B1 (en) 1995-06-07 2001-01-09 Biogen, Inc. Method of making and binding CAIP polypeptides
US6423824B1 (en) 1995-06-07 2002-07-23 Biogen, Inc. CAIP-like gene family
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
WO1997049808A1 (en) * 1996-06-27 1997-12-31 Biogen, Inc. The caip-like gene family
US7309692B1 (en) * 1996-07-08 2007-12-18 Board Of Regents, The University Of Texas System Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en) 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
EP0998945A1 (de) * 1998-09-30 2000-05-10 Transgene S.A. Verwendung von Magnesium (Mg2+) zur Erhöhung der Gen-Verabreichung bei Gentherapie
ATE450621T2 (de) 2000-03-30 2009-12-15 Whitehead Biomedical Inst Mediatoren von rns-interferenz, die rns- sequenzspezifisch sind
KR100872437B1 (ko) 2000-12-01 2008-12-05 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. Ｒｎａ 간섭을 매개하는 작은 ｒｎａ 분자
EP1460898A4 (de) * 2002-01-03 2006-05-24 Univ Texas Wt1-antisense-oligos für die hemmung von brustkrebs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU667803B2 (en) * 1991-01-18 1996-04-18 New York University A receptor tyrosine kinase target protein cDNA cloning method and hGRB proteins
WO1994007913A1 (en) * 1992-09-25 1994-04-14 Warner-Lambert Company Peptide antagonists of sh2 binding and therapeutic uses thereof

Also Published As

Publication number Publication date
FI120499B (fi) 2009-11-13
WO1995007981A1 (fr) 1995-03-23
NZ266162A (en) 1997-11-24
HU221516B (hu) 2002-11-28
SK281123B6 (sk) 2000-12-11
NO960965D0 (no) 1996-03-08
CA2169938A1 (fr) 1995-03-23
DE69426121T2 (de) 2001-05-31
FI961202L (fi) 1996-03-14
JPH09502357A (ja) 1997-03-11
NO319144B1 (no) 2005-06-27
HUT74273A (en) 1996-11-28
GR3034600T3 (en) 2001-01-31
EP0719328B1 (de) 2000-10-11
PT719328E (pt) 2001-02-28
ES2152313T3 (es) 2001-02-01
ZA947059B (en) 1995-05-18
PL313445A1 (en) 1996-07-08
FI961202A0 (fi) 1996-03-14
DK0719328T3 (da) 2000-11-13
RU2159815C2 (ru) 2000-11-27
USRE37952E1 (en) 2002-12-31
HU9600668D0 (en) 1996-05-28
CZ75896A3 (en) 1996-06-12
AU6724794A (en) 1995-04-03
IL110942A (en) 2001-12-23
SK34596A3 (en) 1996-07-03
DE69426121D1 (de) 2000-11-16
AU698819B2 (en) 1998-11-05
PL178402B1 (pl) 2000-04-28
CZ288882B6 (cs) 2001-09-12
CN1098930C (zh) 2003-01-15
CN1133064A (zh) 1996-10-09
KR100330477B1 (ko) 2002-12-02
JP3794697B2 (ja) 2006-07-05
FR2710074A1 (fr) 1995-03-24
US5831048A (en) 1998-11-03
UA46715C2 (uk) 2002-06-17
BR9407693A (pt) 1997-02-04
EP0719328A1 (de) 1996-07-03
IL110942A0 (en) 1994-11-28
IL126756A (en) 2006-06-11
NO960965L (no) 1996-03-08
FR2710074B1 (fr) 1995-12-08

Similar Documents

Publication Publication Date Title
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
HU9501963D0 (en) 7-deazapurine modified oligonucleotides
DE69426121D1 (de) Gen grb3-3, variante und ihre verwendungen
CA2170515A1 (en) Nucleotide sequences for novel protein tyrosine phosphatases
AR015687A2 (es) Gen aislado que codifica acil transferasa
DK1908772T3 (da) Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
GR3029454T3 (en) Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
WO2001071007A3 (en) GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
IL155878A0 (en) Isolated luciferases and the use thereof
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
PE20399A1 (es) Muteina ob
ZA982009B (en) Isolated nucleic acid molecules encoding SSX family members and uses thereof.
NO981707L (no) Xylanase, oligonukleotidsekvens som koder for xylanase og anvendelse derav
WO2002083727A3 (de) Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse
WO2003057835A3 (en) Pak5-related compositions and methods
IT1256078B (it) Ligandi kit solubili

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee